期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

其他药物与氯吡格雷的相互作用 被引量：1

下载PDF
导出
摘要 急性冠状动脉综合征（ACS）起病急、变化快、死亡率高，是危害人类健康最严重的疾病之一。经皮冠状动脉介入治疗（PCI）已成为ACS患者行血运重建的重要手段，然而PCI术后仍有一定冠脉支架内急性、亚急性血栓的发生率。抗血小板治疗能预防和治疗血栓形成，成为治疗ACS患者PCI术后血栓的重要方法。氯吡格雷是一种血小板聚集抑制剂，可以有效预防动脉粥样硬化患者缺血性事件的发生，阿司匹林抵抗者由于血小板对腺苷二磷酸（adeno．sinedip．hosphate，ADP）的敏感性增加，也可以从中获益。
作者 高达 周建庆
机构地区 宁波大学医学院 宁波大学医学院附属李惠利医院
出处 《现代实用医学》 2008年第9期670-671,675,共3页 Modern Practical Medicine
关键词 氯吡格雷 经皮冠状动脉介入治疗 相互作用 急性冠状动脉综合征 血小板聚集抑制剂 抗血小板治疗 PCI术后 亚急性血栓
分类号 R973.2 [医药卫生—药品] R654.2 [医药卫生—外科学]
  • 相关文献

参考文献20

  • 1王嘉莉,柯元南.氯吡格雷抵抗的临床研究现状[J].中日友好医院学报,2007,21(1):44-46. 被引量：9
  • 2Clarke TA,Waskell LA.The Metabolism of clopidogrel is catalyzed by human cytochrome P450 3A and is inhibited by at orvastatin [J].Drug Metab Dispos,2003,31 (1):53-59.
  • 3Mitsios JV, MSc,Papathanasiou AI, Roclis FI, et al. Atorvastatin soes not affect the antiplatelet potency of clopidogrel when it is administered concomitantly for 5 weeks in patients with acute coronary syndromes[J].Circulation,2004.109(11):1335-1338.
  • 4周京敏,葛均波.氯吡格雷和他汀药物的相互作用[J].中华医学杂志,2005,85(40):2870-2872. 被引量：15
  • 5Lau WC, Waskeil LA, Watkins PB, et al. Atorvastatin reduces the ability ofclopidogrel to inhibit platelet aggregation:a new drug-drug interaction[J]. Circulation, 2003,107(1):32-37.
  • 6Lim M J, Spencer FA, Gore JM, et al.Impact of combined pharmacologic treatment with clopidogrel and a star in on outcomes of patients With nonST-segment elevation acute coronary syndromes: perspectives from a large multinational registry [J]. Eur Heart J, 2005,26(11):1063-1069.
  • 7Brophy JM, Babapulle MN, Costa V, et al. A pharmaco epidemiology study of the in teraction between atorvastatin and clopidogrel after percutaneous coronary intervention [J]. Am Heart 3,2006,152(2):263-269.
  • 8Steinhubl SR, Akers WS. Clopidogrel statin interaction: a mountain or a mole hill[J]. Am Heart 3,2006,152(2):200-203.
  • 9Wenaweser P, Windecker S, Billinger M, et al. Effect of atorvastatin and pravastatin on platelet Inhibition by aspirin and elopidogrel treatment in patients with coronary stent thrombosis[J]. Am J Cardiol, 2007,99(3>353-356.
  • 10Lotfi A,.Schweiger MJ, Giugliano GR, et al. High-dose atorvastatin does not negatively influence clinical outcomes among elopidogrel treated acute coronary syndrome patiets-A Pravastatin or Atorvastatin Evaluation and Infection Therapy-Thrombolysisin Myocardial Infarction 22(PROVE ITTIMI 22) analysis[J].Am Heart J,2008,155 (5):954-958.

二级参考文献40

  • 1周京敏,葛均波.氯吡格雷和他汀药物的相互作用[J].中华医学杂志,2005,85(40):2870-2872. 被引量：15
  • 2Müller I, Besta F, Schulz C, et al. Effects of statins on platelet inhibition by a high loading dose of clopidogrel. Circulation, 2003, 108: 2195-2197.
  • 3Gorchakova O, von Beckerath N, Gawaz M, et al. Antiplatelet effects of a 600 mg loading dose of clopidogrel are not attenuated in patients receiving atorvastatin or simvastatin for at least 4 weeks prior to coronary artery stenting. Eur Heart J, 2004, 25: 1898-1902.
  • 4von Beckerath N, Gorchakova O, Motz A, et al. Full antiplatelet effect of a loading dose clopidogrel in the presence of statin therapy. Circulation, 2003, 108(suppl): IV-160.
  • 5Serebruany VL, Malinin AI, Callahan KP, et al. Statins do not affect platelet inhibition with clopidogrel during coronary stenting. Atherosclerosis, 2001, 159: 239-241.
  • 6Smith SM, Judge HM, Peters G, et al. Multiple antiplatelet effects of clopidogrel are not modulated by statin type in patients undergoing percutaneous coronary intervention. Platelets, 2004, 15: 465-474.
  • 7Saucedo JF, Aude W, Garza L. Statin therapy with atorvastatin or simvastatin does not decrease the antiplatelet effect of clopidogrel or eptifibatide during percutaneous intervention. Circulation, 2003, 108(suppl): 575-579.
  • 8Serebruany VL, Midei MG, Malinin AI, et al. Absence of interaction between atorvastatin or other statins and clopidogrel: results from the interaction study. Arch Intern Med, 2004, 164: 2051-2057.
  • 9Serebruany VL, Steinhubl SR, Hennekens CH. Are antiplatelet effects of clopidogrel inhibited by atorvastatin? A research question formulated but not yet adequately tested. Circulation, 2003, 107: 1568-1569.
  • 10Wienbergen H, Gitt AK, Schiele R, et al. Comparison of clinical benefits of clopidogrel therapy in patients with acute coronary syndromes taking atorvastatin versus other statin therapies. Am J Cardiol, 2003, 92: 285-288.

共引文献21

同被引文献4

引证文献1

现代实用医学
2008年 第9期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部